Disorders of the nervous system—including brain disorders—represent one of the most significant challenges to modern medicine in terms of human suffering, lost potential, and financial burden for both families and the nation. Surgical interventions such as deep-brain stimulation have been effective for treating some of these disorders, but they carry the risks associated with any brain surgery. Noninvasive technologies are needed to treat disorders such as epilepsy, Parkinson’s disease, chronic pain, and major neuropsychiatric disorders such as intractable depression. A noninvasive approach to modulating the brain’s intrinsic activity to treat such disorders would have major therapeutic and market potential.
Dr. William “Jamie” Tyler is developing such an approach. He has developed several technologies, including devices and applications, that apply pulsed ultrasound noninvasively to directly modify the molecular substrates of nerve cells to change their electrical signaling properties in a controllable fashion. Dr. Tyler, who has received international attention for this research, expects his work to provide a foundation for the design and implementation of brain stimulation therapies useful in managing a host of neurological diseases. Join us on July 19th and learn about these new technologies from Dr. Tyler.